Detecting epistatic interactions in GWAS (genome-wide association studies) data is of great significance in studying common and complex diseases; however, the ability to detect high-order epistatic interactions in GWAS data is still insufficient. Existing methods are usually used to identify two-order interactions, and they cannot detect a large number of interactions. In this article, we propose a novel stochastic approach named SHEIB-AGM (stochastic approach for detecting high-order epistatic interactions using bioinformation with automatic gene matrix). SHEIB-AGM utilizes bioinformation to construct a gene matrix. In each iteration, it randomly generate a high-order SNP combination based on the gene matrix. SHEIB-AGM utilizes k2 (the Bayesian network scoring criterion) and G-test to detect epistasis in the generated combination and automatically update the gene matrix. We have compared SHEIB-AGM with six other methods, i.e., DECMDR, SNPHarvester, MACOED, AntEpiSeeker, HS-MMGKG and SEE, on simulated data including 108 epistatic models and 17,600 files. The results demonstrate that SHEIB-AGM greatly outperforms the above methods in terms of F-measure and power. We utilized SHEIB-AGM (with and without bioinformation) to analyze a real GWAS dataset from the Wellcome Trust Case Control Consortium.
I. INTRODUCTION
Thanks to the development of high-throughput sequencing technology, it is feasible to measure hundreds of thousands of SNP (single nucleotide polymorphism) [1] , [2] genotypes from thousands of individuals. Genome-wide association studies (GWAS) [3] - [8] play a very important role in identifying the causes of common and complex diseases. They aim to detect relationships between SNPs and phenotype (disease status) by analyzing GWAS data. The GWAS data typically The associate editor coordinating the review of this manuscript and approving it for publication was Wei Wang . contain thousands of samples (diseased samples and normal samples) and hundreds of thousands of SNPs. Many SNPs related to a certain phenotype have been discovered [9] - [14] . To understand the underlying causes of common and complex diseases, considering joint genetic effects (epistasis) across the whole genome is necessary. However, this creates huge computational complexity in the analysis. Epistasis [15] - [20] is a phenomenon in which the effect of an SNP depends on other SNPs. It is widely accepted that complex traits or diseases may be caused by many SNPs. The pathogenic SNPs may show minimal effects individually but strong effects jointly. These are epistatic interactions.
In recent years, numerous methods have been proposed for detecting epistatic interactions [21] - [30] . MDR (multifactordimensionality reduction) [21] is a method for reducing the dimensionality of multilocus information to improve the identification of polymorphism combinations associated with disease risk. MDR is nonparametric and can be utilized to detect high-order epistatic interactions. The original MDR is very time consuming. It can only be used on data containing dozens of SNPs. DECMDR [22] is a method that combines the DE (differential evolution) algorithm with CMDR (classification-based multifactor-dimensionality reduction). It uses the CMDR as a fitness measure to evaluate the solutions in the DE process for scanning the epistatic interactions in GWAS. SNPHarvester [24] is a stochastic search method used to detect epistatic interactions. SNPHarvester greatly reduces the number of SNPs. MACOED [25] is a multi-objective heuristic optimization methodology for detecting epistatic interactions. MACOED combines two complementary evaluation objectives from logistical regression and Bayesian network methods to evaluate SNP combinations. MACOED uses a memory-based multi-objective ACO (ant colony optimization) algorithm. AntEpiSeeker [26] is a two-stage ant colony optimization algorithm. In the first stage, AntEpiSeeker searches SNP combinations of sufficient size using ACO. In the second stage, it conducts an exhaustive search of epistatic interactions within the highly suspected SNP combinations and the reduced set of SNPs with top ranking pheromone levels. HS-MMGKG [29] is also a multi-objective heuristic optimization methodology. It uses harmony search with five objective functions. SEE [30] is a multi-objective evolutionary algorithm that uses eight evolution objectives. Four of these objectives are widely used to measure the relationship between SNP combinations and phenotype in GWAS. The other four objectives are measures of the difference between an SNP combination and its best element. Although a variety of methods have been proposed, the ability to detect epistatic interactions is still insufficient, especially in detecting high-order interactions.
In this work, we propose a novel stochastic approach named SHEIB-AGM (stochastic approach for detecting high-order epistatic interactions using bioinformation with automatic gene matrix). Compared with other methods, SHEIB-AGM has the following main advantages: 1) SHEIB-AGM does not need users to specify the order of the epistatic interactions. It automatically calculates mo (maximum order) based on the number of samples in the GWAS data, and mo can also be specified by the user. SHEIB-AGM can detect any-order (∈ [2, mo)) interactions. 2) SHEIB-AGM is a stochastic approach. In each iteration, it randomly generates an SNP combination that contains mo SNPs. There is minimal relationship between iterations; thus, SHEIB-AGM is parallelizable. Users can specify the number of threads by setting the local parameter.
3) SHEIB-AGM can build a gene matrix (associated Genes) based on bioinformation (if provided by users). In each iteration, the SNP combination can be generated based on the gene matrix, and the matrix is updated based on whether an epistatic interaction is found in the generated combination. By using the matrix, the method greatly improves the performance in detecting epistatic interactions by using bioinformation. 4) SHEIB-AGM utilizes k2 (the Bayesian network scoring criterion) to find an epistatic interaction in the generated SNP combination and G-test to determine whether the interaction is significant. Thus, it can detect any-order (∈ [2, mo)) epistatic interactions. 5) In the implementation of SHEIB-AGM, it utilizes a Boolean representation to save the GWAS data. SHEIB-AGM utilizes logical operations to calculate k2 and G-test based on the representation. Because the gene matrix is symmetrical, to avoid wasting memory, it utilizes an array to save the gene matrix. All these details of the implementation improve the speed and reduce the memory consumption of SHEIB-AGM. To show the performance of SHEIB-AGM, we have conducted a lot of experiments both on simulated GWAS data and real GWAS data. We have compared SHEIB with DECMDR, SNPHarvester, MACOED, AntEpiSeeker, HS-MMGKG and SEE on 3 simulated datasets including 108 epistatic models and 17600 files. The results indicate that SHEIB-AGM greatly outperforms the other six methods in terms of F-measure and power, especially in detecting 3rdorder epistatic interactions.
We have utilized SHEIB-AGM (with and without bioinformation) to analyze a real GWAS dataset from WTCCC (the Wellcome Trust Case Control Consortium) [31] . The results demonstrate that SHEIB-AGM can greatly improve the detection ability by using bioinformation. SHEIB-AGM found many epistatic interactions of varies of order. Some of the detected genes have evidence in the CTD database (the Comparative Toxicogenomics Database) [32] . We have drawn SNP networks and gene networks based on the epistatic interactions found by SHEIB-AGM.We have detected many novel genes, which may play a key role in the seven complex diseases studied in the WTCCC dataset, including STK32A-AS1, FAM155B, MTRNR2L10, SNHG14, NCK1-AS1, MIR1254-1, CSAG4, MIR1254-1, and MEIOB. We believe that SHEIB-AGM is a powerful tool to help us in understanding pathogenesis of common and complex diseases.
II. MATERIALS AND METHODS

A. HARDWARE
All experiments were performed on a computer using a Linux system with 48G of RAM and AMD Ryzen Threadripper 1950X CPU. 
B. SHEIB-AGM ALGORITHM
SHEIB-AGM is a stochastic algorithm. In each iteration, it randomly generates an SNP combination containing mo SNPs based on bioinformation. If the k2 value of the combination is less than the average value, SHEIB-AGM will try to detect an epistatic interaction on the combination. The pseudo code is shown in Algorithm 1, and detailed descriptions are given in the subsequent subsections.
C. THE BOOLEAN REPRESENTATION AND OPERATION OF GWAS DATA
SHEIB-AGM utilizes a Boolean representation and operation of GWAS data to reduce the computing time and memory consumption, which is very similar to BOOST [33] . Fig. 1 shows the Boolean representation of the GWAS data. In Fig. 1 , suppose that the GWAS data contain n SNPs, m0 controls, and m1 cases. In SHEIB-AGM, mem0 and mem1 are utilized to store genotype data of controls and cases, respectively. mem0 is a vector of length n. mem0[i] (i ∈ [0, n)) is a vector of length 3 and stores the genotype data of the ith
)) can only be 1 or 0. If the genotype of the ith SNP and kth control sample is j,
[k] is 1; otherwise, it is 0. The structure of mem1 is similar to mem0. For each SNP and sample, SHEIB-AGM only needs 3 bits to store the genotype. This greatly reduces the memory consumption of the GWAS data. Fig. 2 shows how to calculate k2 or G-test for SNP combination [1, 2] in SHEIB-AGM. In Fig. 2 , suppose that each SNP has only two possible genotypes (0 or 1). The GWAS data contain 8 cases and 8 controls. It uses the Boolean operation to construct a contingency table for the combination. k2 and G-test can be calculated based on the table. The calculation takes advantage of the Boolean operation on the Boolean representation of the GWAS data; thus, it greatly reduces the computing time.
The computation complexity of the Boolean operation in Fig. 2 
Where o is the number of SNPs contained in the SNP combination. m is the number of samples in the GWAS data. The computation complexity seems to be very high, but most of the operations are Boolean logic operations, so the speed is very fast. The speed improvement of the storage structure and Boolean operation has been proved in other studies [29] , [30] , [33] .
D. CALCULATE MO BASED ON THE NUMBER OF SAMPLES
In contrast to other methods, SHEIB-AGM does not need users to specify the order of the epistatic interactions. SHEIB-AGM detects epistatic interactions whose order is less than mo (maximum order). mo can be specified by the users or calculated based on the number of samples of GWAS data [24] . If mo is less than 0, SHEIB-AGM will calculate mo as shown in (1) .
In (1), mo is the maximum order. m * ,0 is the number of controls. m * ,1 is the number of samples. In this work, we do not strictly deduce the formula of mo. The larger the value of mo, the stronger the detection ability of SHEIB-AGM. Howerver, the too large value of mo may make many cells in the multi-SNP comtingence table only have very small number of samples. This will make the calculation of k2 function inaccurate. In order to ensure the effectiveness of k2 function, we expect that the average number of samples in each unit of the contingency table is 3, so min (m * ,0 ,m * ,1 ) 3 mo = 3. In (1), we use e (Euler's Number) to approximate 3 and round the calculation result of mo.
E. LOAD BIOINFORMATION INTO MEMORY
In this work, the bioinformation is given in a file that records the mapping between SNPs and genes. It can be obtained from dbSNP [34] , which is a database established by NCBI (the National Center for Biotechnology Information) [35] . For each SNP in the WTCCC data (the real GWAS data ), we obtained the gene or genes related to it in the dbSNP database.
To use bioinformation in SHEIB-AGM, we have made two very reasonable assumptions. According to Assumption 1, the algorithm should have bias such that it can tend to detect epistasis between SNPs on the same gene. According to Assumption 2, the algorithm should have bias such that it can tend to detect epistasis between SNPs on the genes in which an epistatic interaction has been found.
Assumption 1: Epistasis usually occurs within genes.
Assumption 2:
The epistasis between different genes is regular. If we have found epistatic interactions on different genes, we will likely detect more interactions on the genes.
In SHEIB-AGM, as shown in Fig. 3 , three variables are constructed based on gene-mapping data. snp2Genes is utilized to obtain SNPs located in a gene. gene2Snps is utilized to obtains genes in which an SNP is located. associatedGenes is a gene matrix. In each iteration, SHEIB-AGM tends to detect epistasis in an SNP combination whose corresponding genes have lager values in the gene matrix. According to Assumption 1, during initialization, we make the diagonal values of the matrix 1 and the non-diagonal values minRate. The formula for minRate is shown in (2). In Fig. 3 ,
The Pseudo Code of SHEIB-AGM Algorithm Require: pathIn is the path of GWAS data; pathOut is the path of result; pathS2G is the path of the file which records bioinformation; mo is the maximum order, SHEIB-AGM will detect epistatic interactions whose orders are less than mo; maxGen is the maximum number of iterations; Ensure: epistatic interactions; 1: procedure SHEIB-AGM(pathIn,pathOut,pathS2G,mo,maxGen) 2: read from pathIn and save GWAS data in memory using the Boolean representation; 3: if mo == −1 then 4: calculate mo based on the number of samples; 5: end if 6: initialize snp2Genes = null; gene2Snps = null; associatedGenes = null; G = 0; meanK 2 = 0; results = empty set; 7: if pathS2G = null then 8: construct snp2Genes and gene2Snps based on the content of pathS2G; 9: construct gene matrix (associatedGenes); 10: end if 11: while G < maxG do 12: randomly generate an SNP combination x based on the bioinformation; 13: calculate k2 of x as k2x; 14: meanK 2= meanK 2 * G+k2x
G+1
; 15: if k2x < meanK 2 then 16: try to detect epistatic interaction on x; 17: if an interaction is found then 18: determine whether the interaction is significant based on G-test; 19: if the interaction is significant then 20: add the interaction into results; 21: end if 22: end if 23: end if 24: update associatedGenes based on whether a new interaction is found in this iteration. 25 :
end while 27: end procedure suppose that there are 6 SNPs and 4 genes in the GWAS data. snp2Genes is a hash map. Its key represents an SNP, and its value represents the genes associated with the SNP. gene2Snps is also a hash map. Its key represents a gene, and its value represents the SNPs associated with the gene. In the three variables, the 0th gene represents the unknown gene. All SNPs that are not located in any genes are thought to be located in the unknown gene. associatedGenes is a symmetric matrix. It maintains a value for each pair of genes (including the unknown gene). In this figure, pb is set to 0.8.
In (2), pb is a parameter specified by the users. nGenes is the number of genes in the GWAS data.
F. GENERATE AN SNP COMBINATION BASED ON THE GENE MATRIX
In each iteration of SHEIB-AGM, it generates an SNP combination based on associatedGenes. As shown in Algorithm 2, when x visits a new gene, nextGenes is updated based on associatedGenes. While generating each SNP for x, except for the first SNP, SHEIB-AGM uses roulette to randomly select a gene based on nextGenes and randomly selects an SNP in the selected gene to insert into x. If bioinformation is not provided, it will generate a completely random SNP combination.
G. DETECT AN EPISTATIC INTERACTION ON AN SNP COMBINATION BASED ON K2
The Bayesian network scoring criterion (k2) [36] is widely used in detecting epistatic interactions. The formula for k2 is shown in (3) .
In (3), k2 is the score used to measure the association between an SNP combination and the phenotype. S represents an SNP combination. Y represents the phenotype. C is the set of the genotype combinations of S (if S contains l SNPs, C will be a set of 3 l ). m c, * is the number of samples whereby the genotype combinations of the SNP combinations are c. m c,0 Algorithm 2 Generate an SNP Combination Based on Associatedgenes Require: mo is the maximum order; n is the number of SNPs in the GWAS data; nGenes is the number of genes in the GWAS data; snp2Genes, gene2Snps and associatedGenes are the variables containing bioinformation; rand() is a function which returns a random decimal ∈ [0, 1); Ensure: an SNP combination x; 1: procedure RanGen(mo,n,nGenes,snp2Genes,gene2Snps,associatedGenes) 2: initialize a vector x of length mo; 3: initialize visitedGenes as an empty hash map; 4: initialize nextGenes as a vector of length nGenes + 1; 5: ti = rand(0, n);
6:
x[0] = ti; 7: for i ∈ [1, mo) do 8: if snp2Genes = null then 9: for each gene g ∈ snp2Genes[ti] do 10: if g ∈ visitedGenes then 11: visitedGenes[g]+ = 1; end if 16: end for 17: calculate the sum of nextGenes as s; 18: s = rand() * s; 19: for j ∈ [0, nGenes) do 20: s− = nextGenes[j]; 21: if s < 0 then 22: randomly select an SNP from gene2Snps[j] as ti; 23: break; 24: end if 25: end for 26: else 27: randomly select an SNP from the SNPs which are not in x; 28: end if 29: x[i] = ti and ensure that all elements in x are in ascending order; 30: end for 31: end procedure is the number of controls whereby the genotype combinations are c. m c,1 is the number of cases whereby the genotype combinations are c. k2(Y , S) can measure the quality of the Bayesian network constructed using S and Y . If k2(Y , S) is smaller, the Bayesian network is more accurate, and the association between S and Y is more significant. When an SNP x is removed from S, if x is a noise variable (x has no effect on the phenotype), the quality of the Bayesian network will be improved, and k2(Y , S) will be smaller. If x is associated with the phenotype or x has epistasis with any one of the other SNPs in S, k2(Y , S) will be larger. The change in k2(Y , S) is very useful in detecting an epistatic interaction on an SNP combination. As shown in Algorithm 3, each SNP in the combination is removed to check if the SNP is associated with the phenotype or if it is a part of an epistatic interaction. SHEIB-AGM will attempt to remove SNPs until it cannot remove anyone of them. If the final combination after the removal contains more than two SNPs, it will be an epistatic interaction.
H. DETERMINE WHETHER THE INTERACTION IS SIGNIFICANT BASED ON G-TEST
In SHEIB-AGM, epistatic interactions are divided into significant interactions and non-significant interactions. Using Algorithm 3, we can detect numerous epistatic interactions. In this subsection, SHEIB-AGM determines whether the interactions are significant by using G-test. G-test [37] is a likelihood-ratio or maximum likelihood statistical significance test. If the interaction is not associated with the phenotype, the distribution of G-statistic will be approximately a chi-squared distribution. It is widely used to screen out significant interactions. In this work, we utilize the p-value of G-test (g) and the change in g (gc) [30] to screen out the significant interactions. The formulas for g and gc are shown
Algorithm 3 Detect an Epistatic Interaction on an SNP Combination Based on k2
Require: mo is the maximum order; x is the SNP combination generated by SHEIB-AGM, it contains mo SNPs; k2x is the k2 value of x; Ensure: an epistatic interaction whose order is in [2, mo) or nothing; 1: procedure DetectEpi(mo,x,k2x) 2: initialize l = mo; 3: while l = 1 do 4: for i ∈ [0, l) do 5: bBreak = false; 6: initialize xx as a vector of length l − 1; 7: copy all SNPs of x into xx, except x[i]; 8: calculate k2 of xx as k2xx; 9: if k2xx < k2x then 10: x = xx; 11: k2x = k2xx; 12: l = l − 1; 13: bBreak = true; 14: break; 15: end if 16: end for 17: if bBreak == false then 18: break; 19: end if 20: end while 21: if l > 1 then 22: return x as the epistatic interaction; 23: end if 24: end procedure in (4) , as shown at the bottom of the next page. The interactions whose g and gc are both less than the thresholds specified by the users are significant. The significant interactions are recorded in the result file.
In (4), g(Y ; S) is the p-value of G-test. Y represents the phenotype. S represents an SNP combination. p − value_of represents the function used to compute the p-value of the chi-square distribution. C is the set of the genotype combinations of S (if S contains l SNPs, C will be a set of 3 l ). m is the number of samples. m c,0 is the number of controls whereby the genotype combinations are c. m c,1 is the number of cases whereby the genotype combinations are c. m c, * is the number of samples whereby the genotype combinations of the SNP combinations are c. m * ,0 is the number of controls. m * ,1 is the number of cases. min E∈S g(Y ; E) represents the g of the SNP whose g is the smallest in S.
I. UPDATE GENE MATRIX
In this subsection, we describe how to update the gene matrix. After the initialization, the diagonal values of the matrix are 1, and the non-diagonal values are minRate (very small). In each iteration, if a significant epistatic interaction is found, each pair of the genes in which SNPs in the interaction are located will be set to 1 in the gene matrix (according to Assumption 2). In the subsequent iterations, the tendency to detect epistasis between the genes will increase. If SHEIB-AGM cannot detect a significant interaction in the SNP combination generated by Algorithm 2, each pair of the genes in which the SNPs in the combination are located will decrease, as shown in (5) . In the subsequent iterations, the tendency to detect epistasis between the genes will decrease.
In (5) , as shown at the bottom of the next page, associatedGenes [i, j] is the value between the ith gene and jth gene in the gene matrix. decRate is a parameter specified by the users.
III. RESULTS AND DISCUSSION
A. EXPERIMENTS ON SIMULATED DATA 1) SIMULATED DATASETS
In this work, we compared SHEIB-AGM with six other methods, DECMDR [22] , SNPHarvester [24] , MACOED [25] , AntEpiSeeker [26] , HS-MMGKG [29] and SEE [30] , on three simulated datasets. All seven software packages and their parameter settings are shown in Table 1 . DECMDR, MACOED, HS-MMGKG and SEE can detect any specified order epistatic interactions. SNPHarvester and AntEpiSeeker can only detect 2-order interactions. Although AntEpiSeeker was designed to detect any specified order interactions, when we executed it to detect 3-order interactions, ''segment fault'' occurred. The three simulated datasets are as follows: [38] . The penetrance tables of the 68 models are shown in Table S1 in the Supplementary Appendix.
• DME and DNME 1000: This dataset is the same as DME and DNME 100, except that in this dataset, each simulated GWAS file contains 1000 SNPs. 
, if min Table S2 in the Supplementary Appendix. All three simulated datasets were generated by GAMETES_2. 1 based on their penetrance tables.
2) EVALUATION CRITERIA
In this work, we utilize the F-measure [25] , [30] and power [22] , [39] to evaluate the performance of the methods. They are both widely used criteria to evaluate the ability to detect epistatic interactions. The F-measure and power are calculated as shown in (6) . For each disease model, the algorithm detects epistatic interaction in 100 GWAS files. The power represents the rate at which we have detected the true epistatic interaction in the files. For each model and each In (6) , power and F − measure are the two evaluation criteria used in this work. #(S) means the number of files (100 files in total) in which the algorithm has detected the true epistatic interaction. TP (true positive) is the number of true epistatic interactions found by the algorithm. FN (false negative) is the number of true epistatic interactions not found by the algorithm. FP is the number of SNP combinations which are not epistatic interactions and not found by the algorithm.
3) COMPARISON OF SEHIB-AGM WITH EXISTING METHODS ON SIMULATED DATA
On the DME and DNME 100 dataset, we compared SHEIB-AGM with the other methods. The parameters are given in Table 1 . The average powers of DECMDR, SNPHarvester, MACOED, AntEpiSeeker, HS-MMGKG and SEE are 0.328088235, 0.741029412, 0.483823529, 0.918970588, 0.615735294 and 0.5975, respectively. Their average F-measures are 0.328088235, 0.740343191, 0.483350868, 0.224458529, 0.615735294, and 0.5975, respectively. The F-measure and power of SHEIB-AGM are both 0.984558824. Fig. 4 and Fig. 5 show the comparisons between the seven methods with the DME and DNME 100 dataset. It is found that SHEIB-AGM outperforms the other six methods in terms of power and F-measure with this simulated dataset. The detailed experiment results are shown in Table S3 and Table S4 in the Supplementary Appendix.
On the DME and DNME 1000 dataset, there are ten times as many SNPs in the simulated data, and detecting epistasis is more difficult. The parameters were set as in Table 1 . The average powers of DECMDR, SNPHarvester, MACOED, AntEpiSeeker, HS-MMGKG and SEE Fig. 6 shows the F-measure comparisons between the seven methods on this dataset. Fig. S1 in the Supplementary Appendix shows the power comparisons between the seven methods with this dataset. Although there are many more SNPs in the GWAS data, SHEIB-AGM still outperforms the other six methods with respect to power and F-measure. The detailed experimental results are shown in Table S5 and Table S6 in the Supplementary Appendix. On the DNME3 100 dataset, we compared SHEIB-AGM with the other methods in detecting third-order epistatic interactions. The parameters were as listed in Table 1 . The average powers of DECMDR, MACOED, HS-MMGKG and SEE are 0.094, 0.00275, 0.14975 and 0.1565, respectively. Their average F-measures are 0.094, 0.00275, 0.14975 and 0.1565, respectively. The F-measure and power of SHEIB-AGM are both 0.8705. Fig. 7 shows the F-measure comparisons between the five methods with this dataset. Fig. S2 in the Supplementary Appendix shows the power comparisons between the five methods with this dataset. It is found that SHEIB-AGM outperforms DECMDR, MACOED, HS-MMGKG and SEE with respect to power and F-measure on this simulated dataset. The detailed experimental results are shown in Table S7 and Table S8 Table S9 in the Supplementary Appendix gives a description to the WTCCC dataset. We combined the cases of each disease and the controls to construct seven GWAS data. Following the WTCCC's recommendation, we removed some SNPs and samples. For each GWAS data, we also removed the SNPs whose genotype VOLUME 8, 2020 is unchanged in all samples. Table 2 shows the final seven GWAS data.
2) RESULTS ON THE SEVEN WTCCC GWAS DATA USING SHEIB-AGM WITHOUT BIOINFORMATION
According to the previous analysis of the simulation experiments, compared to other methods, the proposed algorithm achieves a good performance on the three simulated datasets. We applied SHEIB-AGM without bioinformation to analyze the seven GWAS data from WTCCC. We set pb = 0.9, decRate = 0.01, cG = 0.05, cGc = 0.05, o = −1, maxGen = 4 × 10 7 , seed = 0, rn = −1, and other parameters as default values.
We have found many epistatic interactions with varying orders, as shown in Table 3 . It is more difficult to detect higher order epistatic interactions than lower order interactions. More detailed results can be found in Table S10 in the Supplementary Appendix (Table S10-S13 can be obtained at https://github.com/sunliyan0000/sheib-agm).
3) RESULTS ON THE SEVEN WTCCC GWAS DATA USING SHEIB-AGM WITH BIOINFORMATION
To verify whether the introduction of bioinformation improves the detection ability of SHEIB-AGM, we applied SHEIB-AGM with bioinformation to analyze the seven GWAS data from WTCCC. We set pb = 0.9, decRate = 0.01, cG = 0.05, TABLE 6. Some of the gene pairs of the epistastic interactions detected on the seven GWAS data using SHEIB-AGM with bioinformation. The complete table is shown in Table S12 in the Supplementary Appendix. cGc = 0.05, o = −1, maxGen = 4 × 10 7 , seed = 0, rn = −1, and other parameters as default values. The detected epistatic interactions are shown in Table 4 . The detailed results can be found in Table S11 in the Supplementary Appendix. Compared to Table 3 , with bioinformation, SHEIB-AGM can detect 33.94∼3069.40-times more epistatic interactions. This represents a good performance in detecting higher order epistatic interactions. The results demonstrate that Assumption 1 and Assumption 2 are reasonable. SHEIB-AGM can use bioinformation to greatly improve the detection ability.
Some of the detected epistatic interactions are shown in Table 5 . The complete list of the interactions is given in Table S11 in the Supplementary Appendix. Based on the dbSNP database, many SNPs can be mapped to genes. We counted the number of occurrences for the genes and gene pairs. Table 6 and Table 7 show the occurrences of each gene and each gene pair, respectively. The genes and gene pairs with high numbers of occurrences may play a very important role in the corresponding disease. For each of the seven diseases, we searched for each detected gene on the CTD database (the Comparative Toxicogenomics Database). As shown in Table 6 and Table 7 , some of the genes have DE (Direct Evidence) or NDE (Not Direct Evidence) on the CTD database. The genes that have NF (Not Found) on the CTD database may be helpful in further understanding the TABLE 7. Some of the genes of the epistastic interactions detected on the seven GWAS data using SHEIB-AGM with bioinformation. The complete table is shown in Table S13 in the Supplementary Appendix. seven diseases. We have utilized Cytoscape [40] to generate SNP networks and gene networks for each disease. Fig. 8 and Fig. 9 are the SNP network and gene network for Bipolar Disorder. The networks for the other six diseases are shown in Fig. S3 -S14 in the Supplementary Appendix.
IV. CONCLUSION
In this article, we propose a novel stochastic approach named SHEIB-AGM to detect epistatic interactions in GWAS. The approach maintains a gene matrix to manage the bioinformation. In each iteration, it randomly generates an SNP combination containing mo SNPs based on the gene matrix. The approach utilizes k2 to detect an epistatic interaction on the combination. According to the detection result, SHEIB-AGM updates the gene matrix. We have conducted extensive experiments on both simulated data and real GWAS data. The experimental results demonstrate that the proposed algorithm outperforms six existing methods: DECMDR, SNPHarvester, MACOED, AntEpiSeeker, HS-MMGKG and SEE. In addition, SHEIB-AGM can use bioinformation to greatly improve the detection ability. We believe that SHEIB-AGM is a powerful tool for helping us understand the pathogenesis of common and complex diseases.
